SIGN UP
LOG IN
A
ATOS
Atossa Therapeutics Inc
0.86
0.01+1.47%After Hours: 0.8499 -0.01 -0.64%19:55 05/02 EDT
OPEN/PREV CLOSE0.8430/0.8430
TODAY RANGE0.8430-0.8999
VOL528.14K
MARKET CAP110.49M
52 WEEK RANGE0.5526-1.810
AVG VOL (3M)622.05K
% TURNOVER0.41%
TURNOVER--
P/E (TTM)-4.2221
% RANGE6.75%
EPS(TTM)-0.2026
P/E(FORWARD)-3.4216
P/B1.546
BVPS0.5534
DIVIDEND--
P/S0.3716
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP110.42M
SHARES OUTSTANDING129.17M
NEXT EARNINGS05/12-05/16
FREE FLOAT129.09M
LOT SIZE1
EX-DIV DATE04/20/2018
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
Biotech Alert: Searches spiking for these stocks today
Seeking Alpha·3d ago
Atossa wins U.S. patent related to multiple formulation of lead asset
TipRanks·04/22 12:50
Atossa Therapeutics announces issuance of U.S. patent
Dow Jones·04/21 10:17
Atossa Therapeutics Is Maintained at Buy by Ascendiant Capital
TipRanks·04/10 12:10
Atossa Therapeutics and Nona Biosciences partner in breast cancer antibodies
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.